Walgreens Boots Alliance NASDAQ: WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
Name | Walgreens Boots Alliance |
Ticker | WBA |
Exchange | NASDAQ |
Sector | Health Care |
Industry | Healthcare Supply Chain & InfoTech |
Price
52W Low/High |
54.47
33.52 / 56.80 |
Momentum | Weak Up |
Market cap | 47 B |
1Y Total Return |
29.68%
Below Average |
1Y Volatility |
38.53%
Less Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
Details
Ticker | WBA |
Name | Walgreens Boots Alliance |
ISIN | US9314271084 |
CUSIP | 931427108 |
Exchange | NASDAQ |
Sector | Health Care |
Industry | Healthcare Supply Chain & InfoTech |
Country | USA |
Currency | U.S. Dollar |
In Index(ices) | Nasdaq 100 Index |
Share as of 4/14/21
Close Price | 54.47 |
52W Low/High | 33.52 / 56.80 |
Market cap | 47 B |
1Y Total Return |
29.68%
Below Average |
1Y Volatility |
38.53%
Less Risk |
Beta | 0.89 |
PE (trailing) | - |
12M Dividends | 1.86 |
Last Dividend Date | 2/18/21 |
Dividend Yield | 3.41% |
Fin. Strength
Net Profit Margin | -0.4% |
Cash from Op. / Cur. Liabilities | 0.18 |
Diluted Earnings / Share | -0.69 |
ROE | - |
ROIC | 0.0% |
Price / Revenue | 0.3 |
Price / Book | 2.2 |
Price / CF | 8.5 |
Current Ratio | 0.8 |
Cur.Liabilities / Tot.Liabilities | 0.5 |
Financial Leverage | 1.93 |
in Mils USD |
rolling-year up to March
|
||||||
---|---|---|---|---|---|---|---|
Income Statement | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
Revenue |
138,463
|
134,220
|
136,097
|
124,028
|
116,081
|
116,534
|
|
Gross Profit |
27,161
|
28,960
|
30,751
|
29,922
|
29,265
|
29,861
|
|
R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
EBITDA |
1,889
|
6,557
|
8,367
|
7,487
|
7,630
|
6,604
|
|
Operating Income |
791
|
4,310
|
6,001
|
5,966
|
5,582
|
5,069
|
|
Net Income exc. Extra |
-
|
3,493
|
5,133
|
4,134
|
4,247
|
3,368
|
|
per Share | |||||||
Diluted avg Shares |
866
|
886
|
931
|
996
|
1,086
|
1,088
|
|
EPS exc. Extra |
-0.69
|
3.91
|
5.31
|
4.00
|
3.90
|
3.00
|
|
Dividend |
1.86
|
1.81
|
1.72
|
1.58
|
1.49
|
1.42
|
|
Div. Yield (an.) |
3.88%
|
3.96%
|
2.42%
|
2.29%
|
1.72%
|
1.80%
|
|
Balance Sheet | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
Total Assets |
90,920
|
90,003
|
70,434
|
70,816
|
72,505
|
66,385
|
|
Cash, Eq & Invt ShortTerm |
1,030
|
792
|
818
|
1,749
|
11,822
|
3,586
|
|
Total Current Assets |
26,084
|
18,909
|
19,851
|
20,358
|
27,509
|
20,378
|
|
Total Non-Current Assets |
64,836
|
71,094
|
50,583
|
50,458
|
44,996
|
46,007
|
|
Intangibles |
22,954
|
27,717
|
28,959
|
29,237
|
24,864
|
26,918
|
|
Total Liabilities |
68,985
|
65,669
|
45,021
|
42,638
|
42,084
|
36,467
|
|
Total Current Liabilities |
31,246
|
28,662
|
25,303
|
22,559
|
17,678
|
16,272
|
|
Long Term Debt |
37,739
|
37,007
|
19,718
|
20,079
|
24,406
|
20,195
|
|
Shareholder equity |
21,112
|
23,720
|
24,770
|
27,355
|
30,067
|
29,506
|
|
Cash Flow | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
Cash from Operations |
5,556
|
6,883
|
6,250
|
7,081
|
8,144
|
6,412
|
|
Depreciation |
1,906
|
2,017
|
1,902
|
1,681
|
1,725
|
1,740
|
|
Cash from Investing |
-2,036
|
-1,878
|
-2,391
|
-4,802
|
-3,162
|
-120
|
|
Capex |
1,361
|
1,614
|
1,494
|
1,378
|
1,307
|
1,265
|
|
Cash from Financing |
-3,209
|
-5,017
|
-4,794
|
-12,428
|
3,343
|
-5,603
|
|
Stock Issued |
-738
|
-1,896
|
-5,587
|
-7,104
|
-235
|
-1,445
|
|
Debt (LT) Issued |
-563
|
-1,385
|
2,583
|
-3,584
|
5,316
|
-2,565
|
|
Free Cash Flow |
6,679
|
8,836
|
9,284
|
17,236
|
-1,059
|
4,157
|
|
Ratios | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
Net Profit Margin |
-
|
2.6%
|
3.8%
|
3.3%
|
3.7%
|
2.9%
|
|
NCFO / Op.Income |
702.4%
|
159.7%
|
104.1%
|
118.7%
|
145.9%
|
126.5%
|
|
Current Ratio |
0.8
|
0.7
|
0.8
|
0.9
|
1.6
|
1.3
|
|
Financial Leverage D/E |
1.93
|
1.72
|
0.73
|
0.57
|
0.63
|
0.48
|
|
Return on Capital Avg |
0.0%
|
8.1%
|
12.4%
|
10.4%
|
10.1%
|
8.2%
|
|
Return on Shareholder Equity |
-
|
14.4%
|
19.7%
|
14.4%
|
14.3%
|
11.2%
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available